Mercado Global de Lactose de Grau Farmacêutico – Tendências da Indústria e Previsão para 2031

Análise e dimensão do mercado de lactose de grau farmacêutico

O mercado da lactose de qualidade farmacêutica é impulsionado pela crescente procura de excipientes farmacêuticos, impulsionada pela expansão da indústria farmacêutica. O aumento das doenças crónicas, a crescente ênfase nas infra-estruturas de saúde nos mercados emergentes e os avanços nas formulações de medicamentos são factores-chave. As oportunidades residem no desenvolvimento de novas formulações de medicamentos e na expansão das aplicações.

A Data Bridge Market Research analisa que o mercado global de lactose de grau farmacêutico, que foi de 1,67 mil milhões de dólares em 2023, deverá atingir os 2,63 mil milhões de dólares até 2031 e deverá passar por um CAGR de 5,8% durante o período de previsão de 2024 a 2031 .

A “lactose seca por pulverização” domina o segmento de mercado devido à sua capacidade de aumentar a solubilidade e a biodisponibilidade de vários compostos farmacêuticos.

Para além dos insights sobre os cenários de mercado, tais como o valor de mercado, a taxa de crescimento, a segmentação, a cobertura geográfica e os grandes players, os relatórios de mercado com curadoria da Data Bridge Market Research incluem também análises especializadas aprofundadas, produção geograficamente representada pela empresa e capacidade, layouts de rede de distribuidores e parceiros, análise detalhada e atualizada das tendências de preços e análise do défice da cadeia de abastecimento e da procura. 

Âmbito do relatório e segmentação de mercado

Definição de mercado

Pharmaceutical grade lactose refers to a high-purity form of lactose specifically manufactured to meet stringent quality and regulatory standards for pharmaceutical applications. Widely utilized in the pharmaceutical industry, it serves as a crucial excipient in various end-use applications. Pharmaceutical grade lactose finds primary use in formulating tablets, capsules, and inhalation products due to its exceptional binding, bulking, and flow properties.

Pharmaceutical Grade Lactose Market Dynamics

Drivers

• Increasing demand for inhalation and parenteral products

The market is driven by the rising demand for inhalation and parenteral products. Lactose, known for its excellent binding and bulking properties, is extensively used in the pharmaceutical industry to formulate dry powder inhalers and injectable drugs. The growing prevalence of respiratory diseases and the increasing trend toward biologics and biosimilars are fueling the demand for such pharmaceutical formulations, consequently boosting the market for pharmaceutical grade lactose.

• Rising pharmaceutical manufacturing in emerging markets

Emerging markets, including Asia-Pacific and Latin America, are witnessing significant growth in pharmaceutical manufacturing. The expansion of the pharmaceutical industry in these regions is a key driver for the market. As these markets experience increased investments in healthcare infrastructure and research capabilities, the demand for pharmaceutical excipients like lactose is expected to surge, providing substantial growth opportunities for market players.

• Technological advancements in manufacturing processes

Technological advancements in the production processes of pharmaceutical grade lactose contribute to market growth. Continuous efforts are being made to enhance the efficiency and purity of lactose manufacturing, ensuring compliance with pharmaceutical standards. Advanced techniques such as membrane filtration and chromatography are being employed to achieve high-quality pharmaceutical grade lactose, meeting the stringent regulatory requirements and catering to the evolving needs of the pharmaceutical industry.

Restraints

• Stringent regulatory requirements

Stringent regulatory requirements and quality standards pose a challenge to the market. The pharmaceutical industry is subject to rigorous regulations to ensure the safety and efficacy of drugs. Compliance with these standards demands substantial investments in quality control and assurance measures, affecting the overall cost structure and profit margins for manufacturers of pharmaceutical grade lactose.

• Potential for price fluctuations of raw materials

The market for pharmaceutical grade lactose is susceptible to price fluctuations in raw materials, particularly in the dairy industry. Lactose is derived from whey, and variations in milk production, weather conditions, and geopolitical factors can impact the availability and cost of raw materials. Manufacturers need to navigate these uncertainties, potentially affecting production costs and supply chain stability.

Opportunities

• Growing preference for nutraceuticals and dietary supplements

The increasing awareness of health and wellness has led to a growing preference for nutraceuticals and dietary supplements. Pharmaceutical grade lactose, with its use in the production of tablets and capsules for dietary supplements, is poised to benefit from this trend. Manufacturers can leverage this opportunity by developing lactose-based formulations targeted at the expanding market for nutritional and dietary products.

• Focus on research and development for innovative formulations

There is an opportunity for market players to invest in research and development activities to create innovative formulations that incorporate pharmaceutical grade lactose. The development of novel drug delivery systems and specialized pharmaceutical products can open new avenues for growth. Collaborations with pharmaceutical companies and research institutions can facilitate the exploration of novel applications and formulations, allowing companies to differentiate themselves in the market.

Challenges

• Competition from alternative excipients

The global pharmaceutical industry is witnessing the emergence of alternative excipients that may pose a challenge to the market for pharmaceutical grade lactose. As the demand for specialized formulations increases, manufacturers may explore and adopt alternative excipients with specific functionalities, potentially displacing traditional lactose-based formulations.

• Global supply chain disruptions

The market faces challenges related to potential disruptions in the supply chain, such as transportation restrictions, labor shortages, and logistical complexities. Companies need robust contingency plans and supply chain resilience strategies to navigate unforeseen challenges and ensure a steady supply of pharmaceutical grade lactose to meet market demand.

This pharmaceutical grade lactose market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the pharmaceutical grade lactose market contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.

 Recent Development

• In October 2023, Lactalis Ingredients has entered the pharmaceutical sector with the launch of its new brand, Lactalis Ingredients Pharma. Drawing on over 50 years of expertise in lactose production, the company, ranked 6th globally among lactose suppliers, is set to cater to pharmaceutical companies worldwide. The Retiers plant, equipped with state-of-the-art facilities, now complies with ISO 9001, FSSC 22000, and Good Manufacturing Practices standards

Global Pharmaceutical Grade Lactose Market Scope

The pharmaceutical grade lactose market is segmented on the basis of type and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Crystalline Monohydrate Lactose
• Inhalation Lactose
• Granulated Lactose
• Spray Dried Lactose

Application

• Tablets Manufacturing
• Capsule Manufacturing

Global Pharmaceutical Grade Lactose Market Regional Analysis/Insights

The pharmaceutical grade lactose market is analyzed and market size insights and trends are provided by country,  type, and application are referenced above.

The countries covered in the market report are U.S., Canada, Mexico, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, rest of Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America U.A.E., Saudi Arabia, Oman, Qatar, Kuwait, South Africa, and rest of Middle East and Africa.

North America is expected to dominate the market due to a strong pharmaceutical industry, stringent quality standards (FDA), and concentration of major companies.

Asia-Pacific is expected to witness the fastest growth during the forecast period due to the growth fueled by lower manufacturing costs, increasing healthcare investments, and emerging as a key player in pharmaceutical manufacturing in the region in the coming years.

A secção do país do relatório também fornece fatores individuais de impacto no mercado e alterações na regulamentação do mercado interno que impactam as tendências atuais e futuras do mercado. Pontos de dados como a análise da cadeia de valor a jusante e a montante, tendências técnicas e análise das cinco forças de Porter, estudos de caso são alguns dos indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, são considerados a presença e disponibilidade de marcas globais e os desafios enfrentados devido à grande ou escassa concorrência de marcas locais e nacionais, o impacto das tarifas nacionais e as rotas comerciais, ao mesmo tempo que se fornece uma análise de previsão dos dados do país.

Análise do cenário competitivo e da quota de mercado da lactose de grau farmacêutico

O panorama competitivo do mercado da lactose de qualidade farmacêutica fornece detalhes dos concorrentes. os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença global, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa , lançamento de produto, largura e amplitude do produto, domínio da aplicação. Os dados fornecidos acima estão apenas relacionados com o foco das empresas relacionado com o mercado da lactose de grau farmacêutico.

Alguns dos principais players que operam no mercado da lactose de qualidade farmacêutica são:

• PROTEÍNAS DE ARMADURA (França)
• BASF Corporation (EUA)
• Charotar Casein Company (Índia)
• DFE Pharma (Holanda)
• Grupo Fengchen Co., Ltd.
• Alpavit (Suíça)
• Kavya Pharma (Índia)
• Kerry Group plc (Irlanda)
• Ingredientes Lactalis (França)
• Lactose (Índia) Limited (Índia)
• MEGGLE GmbH & Co. KG (Alemanha)
• FrísiaCampina (Holanda)
• Surfachem Group Ltd. (Reino Unido)

SKU-70597